Literature DB >> 27000182

[Connective tissue diseases in adolescents].

J Peitz1,2, I Tantcheva-Poór3.   

Abstract

In this article we provide a brief review of systemic lupus erythematosus, juvenile dermatomyositis, systemic scleroderma, and mixed connective tissue disease in adolescents. As skin manifestations often belong to the presenting symptoms and may have a significant impact on the quality of life, dermatologists play an important role in the management of patients with connective tissue diseases. Early diagnosis and therapy onset are crucial for the patients' long-term outcome.

Entities:  

Keywords:  Adolescent; Juvenile dermatomyositis; Lupus erythematosus; Mixed connective tissue disease; Skin; Systemic scleroderma

Mesh：

Year:  2016        PMID： 27000182     DOI： 10.1007/s00105-016-3772-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  22 in total

Review 1.  Update on pediatric systemic sclerosis: similarities and differences from adult disease.

Authors:  Ivan Foeldvari
Journal:  Curr Opin Rheumatol       Date:  2008-09       Impact factor: 5.006

Review 2.  The Diagnosis and Treatment of Systemic Lupus Erythematosus.

Authors:  Annegret Kuhn; Gisela Bonsmann; Hans-Joachim Anders; Peter Herzer; Klaus Tenbrock; Matthias Schneider
Journal:  Dtsch Arztebl Int       Date:  2015-06-19       Impact factor: 5.594

3.  Results of the German ESPED-recording of new patients with juvenile dermatomyositis (JDM).

Authors:  F Dressler; M Frosch; K Mönkemöller; A Thon; E Weissbarth-Riedel; G Horneff
Journal:  Klin Padiatr       Date:  2011-04-20       Impact factor: 1.349

Review 4.  The management of pediatric systemic lupus erythematosus.

Authors:  Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2005-12

5.  Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Authors:  D J Lovell; C B Lindsley; R M Rennebohm; S H Ballinger; S L Bowyer; E H Giannini; J E Hicks; J E Levinson; R Mier; L M Pachman; M H Passo; M D Perez; A M Reed; K N Schikler; M Smith; L S Zemel; L G Rider
Journal:  Arthritis Rheum       Date:  1999-10

6.  The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.

Authors:  Francesco Zulian; Patricia Woo; Balu H Athreya; Ronald M Laxer; Thomas A Medsger; Thomas J A Lehman; Marco Matucci Cerinic; Giorgia Martini; Angelo Ravelli; Ricardo Russo; Ruben Cuttica; Sheila Knupp Feitosa de Oliveira; Christopher P Denton; Franco Cozzi; Ivan Foeldvari; Nicolino Ruperto
Journal:  Arthritis Rheum       Date:  2007-03-15

Review 7.  Diagnostic workup for mixed connective tissue disease in childhood.

Authors:  Joost F Swart; Nico M Wulffraat
Journal:  Isr Med Assoc J       Date:  2008 Aug-Sep       Impact factor: 0.892

8.  Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.

Authors:  I E A Hoffman; B R Lauwerys; F De Keyser; T W J Huizinga; D Isenberg; L Cebecauer; J Dehoorne; R Joos; G Hendrickx; F Houssiau; D Elewaut
Journal:  Ann Rheum Dis       Date:  2008-10-17       Impact factor: 19.103

9.  Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  L R Sammaritano
Journal:  Lupus       Date:  2014-10       Impact factor: 2.911

10.  Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.

Authors:  R Sundel; N Solomons; L Lisk
Journal:  Lupus       Date:  2012-08-24       Impact factor: 2.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.